126 related articles for article (PubMed ID: 12374652)
21. [Management of adverse effects by cancer chemotherapy for treatment of advanced breast cancers].
Kobayashi T; Fujii T; Yamazaki H; Ohkawa Y; Kuraishi Y; Inagaki J
Nihon Rinsho; 2000 Apr; 58 Suppl():298-310. PubMed ID: 11026010
[No Abstract] [Full Text] [Related]
22. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.
Patt DA; Duan Z; Fang S; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3871-6. PubMed ID: 17664457
[TBL] [Abstract][Full Text] [Related]
23. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
Rutqvist LE
J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
[No Abstract] [Full Text] [Related]
24. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
[TBL] [Abstract][Full Text] [Related]
25. [A Case of Suspected Therapy-Related Leukemia after Chemotherapy for Breast Cancer].
Yano Y; Kuga T; Harada T; Sano F; Inokuchi T; Fujii Y
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1775-1777. PubMed ID: 30587740
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases in HER2-positive breast cancer.
Lin NU
Lancet Oncol; 2013 Mar; 14(3):185-6. PubMed ID: 23414590
[No Abstract] [Full Text] [Related]
27. DNA repair and the risk of secondary leukemias.
Gerson SL
J Clin Oncol; 1996 Feb; 14(2):681-2. PubMed ID: 8636789
[No Abstract] [Full Text] [Related]
28. Controversial issues in adjuvant systemic therapy of early breast cancer.
Rutqvist LE
Acta Oncol; 1998; 37(5):421-30. PubMed ID: 9831370
[TBL] [Abstract][Full Text] [Related]
29. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
Jagavkar RS; Shakespeare TP; Stevens MJ
Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
[No Abstract] [Full Text] [Related]
30. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
[No Abstract] [Full Text] [Related]
31. Side-effects of cancer drugs are under-reported in trials.
Mayor S
Lancet Oncol; 2015 Mar; 16(3):e107. PubMed ID: 25639368
[No Abstract] [Full Text] [Related]
32. [BRAF: the pathologist's favorite oncogene].
Sabourin JC
Ann Pathol; 2013 Dec; 33(6):373-4. PubMed ID: 24331718
[No Abstract] [Full Text] [Related]
33. Doctors less likely than patients to report toxicity of cancer treatments, study shows.
Mayor S
BMJ; 2015 Jan; 350():h485. PubMed ID: 25630342
[No Abstract] [Full Text] [Related]
34. Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer.
Melillo LM; Sajeva MR; Musto P; Perla G; Cascavilla N; Minervini MM; D'Arena G; Carotenuto M
Leukemia; 1997 Dec; 11(12):2211-3. PubMed ID: 9447844
[No Abstract] [Full Text] [Related]
35. Some side effects of breast cancer treatment may be a good sign.
Harv Womens Health Watch; 2009 Jan; 16(5):6. PubMed ID: 19244663
[No Abstract] [Full Text] [Related]
36. Reply to P. Baldo et al.
Perrone F; Di Maio M; Gallo C
J Clin Oncol; 2015 Sep; 33(25):2826. PubMed ID: 26195706
[No Abstract] [Full Text] [Related]
37. The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition.
Vardy J; Dhillon H
Breast Cancer Res Treat; 2010 Aug; 123(1):35-7. PubMed ID: 20052534
[No Abstract] [Full Text] [Related]
38. Second neoplasm--a complication of cancer chemotherapy.
Chabner BA
N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277
[No Abstract] [Full Text] [Related]
39. Leukemia following chemotherapy for breast cancer.
Curtis RE; Boice JD; Moloney WC; Ries LG; Flannery JT
Cancer Res; 1990 May; 50(9):2741-6. PubMed ID: 2328500
[TBL] [Abstract][Full Text] [Related]
40. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
Sack H
Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
